Pharmafile Logo

Gower Publishing

The Pivot

In times of uncertainty it is critical for businesses to take action to protect their brand image and longevity.

Page & Page Health

- PMLiVE

FDA grants emergency authorisation to chloroquine for COVID-19

Novartis and Bayer donate anti-malaria drugs to US stockpile

- PMLiVE

Behaviour change – is there something missing?

Successful and impactful behaviour change requires commitment and time

Bedrock Healthcare Communications

Sanofi reception

Sanofi doses first patient in global Kevzara COVID-19 trial

Sanofi is leading trials outside the US while Regeneron is leading US trials

- PMLiVE

Lundbeck drops Parkinson’s drug acquired in €905m deal

Disappointment after drug failed in a mid-stage clinical trial

- PMLiVE

The global antibiotic crisis: a 2020 perspective

A report from the CDC says the ‘approaching’ post-antibiotic era is already here

- PMLiVE

UK contributes £210m towards COVID-19 vaccine efforts

Prime Minister Boris Johnson also tests positive for coronavirus

- PMLiVE

Bluebird bio pushes back commercial launch of Zynteglo due to COVID-19

First patient is likely to be treated later in the year due to pandemic

- PMLiVE

In virtual meeting, CHMP backs Sanofi’s myeloma drug Sarclisa

Monthly meeting held remotely for the first time due to COVID-19 pandemic

- PMLiVE

COVID-19 delays Pfizer, Mylan’s generics merger and spin-out

Fallout from pandemic continues to affect business in myriad ways

COVID-19 message to clients from OPEN Health CEO, David Rowley

Dear OPEN Health Clients,I want to highlight to our clients what we’re doing in response to the Coronavirus outbreak to protect our staff, our clients and the community.We’re following the...

OPEN Health

- PMLiVE

The march to sustainability

How sustainability can be achieved within the pharma sector and the critically important role of the communicator

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links